Claire Mazumdar, Officer, Director: Bicara Therapeutics BCAX Planned sale · Filed 05/18

Trade details

Type: Planned sale notice
Stock: Bicara Therapeutics BCAX
Person: Claire MazumdarOfficer, Director
Planned sale date: 26/05/18
Filed: 26/05/18

More to sell after $1.5M in 3 months

Bicara Therapeutics trades, last 26 weeks

What else happened in Bicara Therapeutics around then

Filed or reported within 30 days of the trade day · 04/18~06/17

Claire Mazumdar's recent trades

Claire MazumdarOfficer, Director
Planned sale10b5-1 planBicara Therapeutics
Planned sale10b5-1 plan
Bicara Therapeutics
BCAX
$278.3K
10,000 sh
$278.3K
Filed 08/10
Traded 08/10
Claire MazumdarOfficer, Director
Planned sale10b5-1 planBicara Therapeutics
Planned sale10b5-1 plan
Bicara Therapeutics
BCAX
$296.8K
10,000 sh
$296.8K
Filed 07/10
Traded 07/10
Claire MazumdarCEO
Sell10b5-1 planBicara Therapeutics
Sell10b5-1 plan
Bicara Therapeutics
BCAX
$240K
12,022 sh
$240K
Filed 05/20
Traded 05/18
Claire MazumdarCEO
Sell10b5-1 planBicara Therapeutics
Sell10b5-1 plan
Bicara Therapeutics
BCAX
$60.6K
2,978 sh
$60.6K
Filed 05/20
Traded 05/18
Claire MazumdarCEO
Sell10b5-1 planBicara Therapeutics
Sell10b5-1 plan
Bicara Therapeutics
BCAX
$354.2K
15,000 sh
$354.2K
Filed 04/20
Traded 04/20

Claire Mazumdar, Director — plans to sell 15,000 sh of Bicara Therapeutics BCAX · $313.8K · around 05/18 · 10b5-1 plan | Whalegun